AIM-listed biotechnology company Thalia Therapeutics has announced the acquisition of US-based oncology firm Sanmirna Therapeutics alongside an oversubscribed £2.75m fundraise. ...

No Result

View All Result

Home
Artistas
Celebridades
Entretenimiento
Musica
Videos
Edición Brasileña
Edición Internacional
Acerca de Nosotros
Contáctanos

Tag: AIM

Thalia Therapeutics acquires US firm backed by fundraise

Welcome Back!

Retrieve your password